Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

被引：0
|
作者：
Xi Liu
Huili Chen
Yuqi Shang
Hongqiong Zhu
Gongqi Chen
Yuanli Chen
Shaoxuan Liu
Yaoyong Zhou
Mingxing Huang
Zhongsi Hong
Jinyu Xia
机构：
[1] Sun Yat-sen University,Department of Infectious Diseases, The Fifth Affiliated Hospital
[2] Sun Yat-sen University,Department of Hospital Infection Control, The Fifth Affiliated Hospital
[3] Sun Yat-sen University,Office of Clinical Research Center, The Fifth Affiliated Hospital
来源：
Trials | / 21卷
关键词：
COVID-19; Chloroquine; Lopinavir/ritonavir; Randomized controlled clinical study; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
    Liu, Xi
    Chen, Huili
    Shang, Yuqi
    Zhu, Hongqiong
    Chen, Gongqi
    Chen, Yuanli
    Liu, Shaoxuan
    Zhou, Yaoyong
    Huang, Mingxing
    Hong, Zhongsi
    Xia, Jinyu
    [J]. TRIALS, 2020, 21 (01)
  • [2] Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial
    Zhang, Xin-Yi
    Lv, Lang
    Zhou, Yu-Long
    Xie, Liang-Dong
    Xu, Qin
    Zou, Xiao-Fan
    Ding, Yan
    Tian, Jie
    Fan, Jia-Liang
    Fan, Hai-Wei
    Yang, Yi-Xi
    Ye, Xiao-Qun
    [J]. PHYTOTHERAPY RESEARCH, 2021, 35 (08) : 4401 - 4410
  • [3] An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
    Ader, Florence
    Peiffer-Smadja, Nathan
    Poissy, Julien
    Bouscambert-Duchamp, Maude
    Belhadi, Drifa
    Diallo, Alpha
    Delmas, Christelle
    Saillard, Juliette
    Dechanet, Aline
    Mercier, Noemie
    Dupont, Axelle
    Alfaiate, Toni
    Lescure, Francois-Xavier
    Raffi, Francois
    Goehringer, Francois
    Kimmoun, Antoine
    Jaureguiberry, Stephane
    Reignier, Jean
    Nseir, Saad
    Danion, Francois
    Clere-Jehl, Raphael
    Bouiller, Evin
    Navellou, Jean-Christophe
    Tolsma, Violaine
    Cabie, Andre
    Dubost, Clement
    Courjon, Johan
    Leroy, Sylvie
    Mootien, Joy
    Gaci, Rostane
    Mourvillier, Bruno
    Faure, Emmanuel
    Pourcher, Valerie
    Gallien, Sebastien
    Launay, Odile
    Lacombe, Karine
    Lanoix, Jean-Philippe
    Makinson, Alain
    Martin-Blondel, Guillaume
    Bouadma, Lila
    Botelho-Nevers, Elisabeth
    Gagneux-Brunon, Amandine
    Epaulard, Olivier
    Piroth, Lionel
    Wallet, Florent
    Richard, Jean-Christophe
    Reuter, Jean
    Staub, Therese
    Lina, Bruno
    Noret, Marion
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1826 - 1837
  • [4] Efficacy of clarithromycin in patients with mild COVID-19 pneumonia patients: An exploratory, multicenter, open-label, randomized controlled trial
    Yamamoto, Kazuko
    Fukuda, Yuichi
    Sawai, Toyomitsu
    Ide, Shotaro
    Mori, Yusuke
    Hashiguchi, Kohji
    Ishii, Hiroshi
    Futsuki, Yoji
    Iwanaga, Naoki
    Hosogaya, Naoki
    Sakamoto, Noriho
    Yoshida, Haruo
    Takamatsu, Yuki
    Ota, Kenji
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    [J]. RESPIROLOGY, 2023, 28 : 226 - 226
  • [5] An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
    Rea-Neto, Alvaro
    Bernardelli, Rafaella Stradiotto
    Dzivielevski Camara, Bruna Martins
    Reese, Fernanda Baeumle
    Oliveira Queiroga, Marcos Vinicius
    Oliveira, Mirella Cristine
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
    Álvaro Réa-Neto
    Rafaella Stradiotto Bernardelli
    Bruna Martins Dzivielevski Câmara
    Fernanda Baeumle Reese
    Marcos Vinicius Oliveira Queiroga
    Mirella Cristine Oliveira
    [J]. Scientific Reports, 11
  • [7] Efficacy and Safety of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial
    Siami, Zeinab
    Dehghan, Danial
    Khavandegar, Armin
    Lak, Mehran
    Bakhtiyari, Mahmood
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (05)
  • [8] A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
    Fowotade, Adeola
    Bamidele, Folasade
    Egbetola, Boluwatife
    Fagbamigbe, Adeniyi F.
    Adeagbo, Babatunde A.
    Adefuye, Bolanle O.
    Olagunoye, Ajibola
    Ojo, Temitope O.
    Adebiyi, Akindele O.
    Olagunju, Omobolanle I.
    Ladipo, Olabode T.
    Akinloye, Abdulafeez
    Onayade, Adedeji
    Bolaji, Oluseye O.
    Rannard, Steve
    Happi, Christian
    Owen, Andrew
    Olagunju, Adeniyi
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [9] An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
    Ader, Florence
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (09) : 1293 - 1296
  • [10] severe COVID-19 Patients: A Multicenter, Randomized, Open-Label Clinical Trial
    Trinh, Dieu-Thuong Thi
    Tran, An Hoa
    Bui, Minh-Man Pham
    Kieu, Thy Xuan
    Nguyen, Van -Dan
    Thuy, Nguyen Huu Lac
    Thai, Khac-Minh
    Vuong, Nguyen Lam
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
12345